Immunotherapy Weekly articles from July 2002

Immunotherapy Weekly archives from July 2002

Antibody testing improves early detection of respiratory infections.(Brief Article)
July 3, 2002... 2002 JUL 3 - (NewsRx.com & NewsRx.net) -- Testing for the presence of three antibodies against the bacterium that causes lung infections in patients with cystic fibrosis (CF) can help detect the infection 6-12 months before the organism is...

High-dose, tapering method reaps more benefits from steroid in acute rejection.(Brief Article)
July 3, 2002... 2002 JUL 3 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Using high-dose steroid therapy that includes several days of tapering seems be more effective for treating liver transplant recipients with acute rejection....

Update on national guidelines released.(Guidelines for the Diagnosis and Management of Asthma)(Brief Article)
July 3, 2002... 2002 JUL 3 - (NewsRx.com & NewsRx.net) -- The National Asthma Education and Prevention Program (NAEPP), has issued an update of selected topics in the Guidelines for the Diagnosis and Management of Asthma. The guidelines now recommend inhaled...

Collaboration advances potential therapy.(Brief Article)
July 3, 2002... 2002 JUL 3 - (NewsRx.com & NewsRx.net) -- The U.S. Department of Energy's Pacific Northwest National Laboratory (PNNL) has launched a collaboration with two U.S. companies and Russian scientists to develop a more effective treatment for...

Pain isn't all in patients' heads, new brain study finds.(Brief Article)
July 3, 2002... 2002 JUL 3 - (NewsRx.com & NewsRx.net) -- A new brain-scan study confirms scientifically what fibromyalgia patients have been telling a skeptical medical community for years: They're really in pain. In fact, the study found, people with...

Contraction of T cell response not linked to clearance of infection.(Brief Article)
July 3, 2002... 2002 JUL 3 - (NewsRx.com & NewsRx.net) -- The results of a new University of Iowa (UI) study challenge an old assumption about how the immune system responds to an infection and could have important implications for improving vaccine...

Opioid-induced immune suppression can be prevented.(Brief Article)
July 3, 2002... 2002 JUL 3 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States and Europe may have found to a way to prevent the mediating effects of opioids on HIV proliferation. "Opioids potentiate...

Nevirapine tolerance induction safe, effective.(Brief Article)
July 3, 2002... 2002 JUL 3 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Allergic reactions to the antiretroviral agent nevirapine can be prevented in high-risk patients, researchers in France report. "The most frequent...

Arthritis Foundation statement on yoga.(Brief Article)
July 3, 2002... 2002 JUL 3 - (NewsRx.com & NewsRx.net) -- Based on current information, the Arthritis Foundation believes that early research findings indicate yoga may be useful in treating various forms of arthritis. Although there are few studies that...

Labeling changes approved for Celebrex.(Brief Article)
July 3, 2002... 2002 JUL 3 - (NewsRx.com & NewsRx.net) -- The FDA has approved labeling changes for Celebrex (celecoxib) based on the results of the Celecoxib Long-term Arthritis Safety Study (CLASS). CLASS was a prospective double-blind randomized safety...

Genaera presents interim data on Lomucin clinical trial.(Brief Article)
July 3, 2002... 2002 JUL 3 - (NewsRx.com & NewsRx.net) -- Genaera Corp. (GENR) and collaborators presented interim results for its mucoregulator compound, Lomucin in its first therapeutic clinical study in asthma, at the meeting of the American Thoracic...

IDM's first scientific partnership in Canada with McGill University.(Brief Article)
July 3, 2002... 2002 JUL 3 - (NewsRx.com & NewsRx.net) -- The Montreal Centre for Experimental Therapeutics in Cancer, based at the Jewish General Hospital, Paris based biotechnology firm Immuno-Designed Molecules, S.A. (IDM) and its Canadian subsidiary...

Cel-Sci reports flat revenues for first quarter.(Brief Article)
July 3, 2002... 2002 JUL 3 - (NewsRx.com & NewsRx.net) -- Cel-Sci Corp. (CVM) reports revenue for the quarter from January 1, 2002, until March 31, 2002, was $93,050 compared with $87,888 in the same quarter of last year. Revenues were derived from interest...

Hantaan and Sin Nombre virus peptides may be useful for treatment.(Brief Article)
July 3, 2002... 2002 JUL 3 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in South Korea have identified a peptide that may have therapeutic use for treating patients infected with some hantavirus strains. Dr....

FDA approves restricted marketing of Lotronex.(Brief Article)
July 3, 2002... 2002 JUL 3 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has approval a supplemental new drug application (sNDA) that permits marketing of Lotronex (alosetron hydrochloride) with restrictions. The manufacturer...

Hybridon announces patent covering a novel class of oligonucleotides.(Brief Article)
July 3, 2002... 2002 JUL 3 - (NewsRx.com & NewsRx.net) -- Hybridon, Inc. (HYBN.OB) announced the issuance of U.S. Patent No. 6,383,752, claiming a novel class of oligonucleotides with improved functional properties for target validation and therapeutic and...

RSV prevention in first winter protects lungs of preemies for many years.(respiratory syncytial virus )(Brief Article)
July 3, 2002... 2002 JUL 3 - (NewsRx.com & NewsRx.net) -- A short-term treatment to prevent respiratory syncytial virus (RSV) infection in premature infants with lung disease provided significant respiratory and immunologic benefits up to 10 years later,...

Patient accrual for HuMax-IL15 phase I/II study complete.(Brief Article)
July 3, 2002... 2002 JUL 3 - (NewsRx.com & NewsRx.net) -- Genmab A/S announced that it has completed accrual in its phase I/II clinical study with HuMax-IL15 for the treatment of rheumatoid arthritis (RA). Thirty patients have been enrolled in this...

New FDA action on Aslera NDA expected.(new drug application)(Brief Article)
July 3, 2002... 2002 JUL 3 - (NewsRx.com & NewsRx.net) -- Genelabs Technologies, Inc., (GNLB) said the company expects a new U.S. Food and Drug Administration (FDA) action on its New Drug Application (NDA) for Aslera (GL701) no later than the end of August...

Transduced tumor cells are prime candidates for becoming tumor vaccines.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Vaccine and cancer researchers believe immunogene therapy may be a major way to use the body's own immune response system to treat and eradicate certain types...

Protein essential for switching on T-cell response.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- A minor change in a cell protein impairs the ability of a key type of immune cell to marshal the body's defenses against disease, according to a study by researchers at the U.S. National Institute of...

Polyguanosine intensifies immunostimulatory effects of phosphodiester CpG oligodeoxynucleotides.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Polyguanosine runs added at the end of oligodeoxynucleotides (ODN) containing CpG prevented the side effects caused by CpG-containing DNA adjuvants...

Treating bacterial infections can help asthmatics.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- A new study indicates that many patients with asthma may have bacterial infections in their lungs and that treatment with antibiotics can improve their ability to breathe. Researchers at National...

Anticancer mechanisms of donor lymphocyte infusions elucidated.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Europe have shed new light on the beneficial effects of donor lymphocyte infusions for leukemia patients. "Donor lymphocyte infusions (DLI)...

Hepatitis B virus genotype rules outcomes following liver transplantation.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - According to investigators at the Mayo Clinic, patients infected with certain hepatitis B virus (HBV) genotypes sustain a greater risk for viral recurrence and...

Allergy-proofing activities.(Brief Article)(Statistical Data Included)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- In recognition of the start of summer, the makers of Zicam Allergy Relief announced results of a national survey showing that allergies are nothing to sneeze at - no matter what the season. According...

U.S. experts say more research could prevent deaths from food, drug allergy.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- The U.S. should devote more funding to research that looks at allergic reactions - sometimes fatal - to food and drugs, two national medical experts said during a standing-room-only Congressional staff...

New imaging may catch and treat patients early.(magnetic resonance imaging of arthritis)(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- Early detection of arthritis may soon be possible in doctors' offices with new compounds that "light up" joint cartilage in magnetic resonance imaging, according to Gerald Rosen, research professor at...

Research shows promise for new class of anti-inflammatory drug.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- A new type of anti-inflammatory painkiller is showing promise in experiments on people with arthritis in their knees. Research presented at a conference in Stockholm indicated that the drug works...

Medinox initiates phase I trial of MX-1094,.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- Medinox, Inc., announced the start of a phase I safety trial of MX-1094, an NSAID prodrug in development for the treatment of arthritis. The trial is being conducted in the Netherlands and is...

Method for rapid large-scale bacterial identification published.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- Sequenom, Inc., (SQNM) a discovery genetics company, announced that it has developed a method for rapid large-scale bacterial identification, as published in the latest edition of the Proceedings of...

Roche and Genmab expands antibody collaboration.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- Roche and Genmab A/S announced a broad expansion of their current collaboration for the creation and development of human antibody therapeutic products for life-threatening and debilitating diseases....

Islet transplantation doesn't always work.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - In diabetic patients who undergo islet transplantation, episodes of hypoglycemia fail to stimulate glucagon release and counter regulation of hypoglycemia. This...

Clinicians should consider influenza A and B when diagnosing a febrile respiratory illness during the summer.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- The 2001-02 influenza season was mild to moderate in the United States, according to the U.S. Centers for Disease Control and Prevention. Influenza A (H3N2) viruses predominated, but influenza B...

Study: ThGRF peptide improves immune function among elderly.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- Theratechnologies has announced the successful completion of a phase II clinical trial to determine the efficacy and safety profile of the ThGRF (TH9507) peptide on the immune response of elderly...

Monoclonal antibody improves patient response to therapy.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - A new treatment approach for acute myeloid leukemia (AML) that combines a monoclonal antibody with chemotherapy helps to improve patients' response to therapy...

Medarex announces filing of investigational new drug application for MDX-060.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- Medarex, Inc. (MEDX) announced the filing of an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) to initiate phase I clinical trials of MDX-060, a fully human...

Advancements announced in treatment of MS.(multiple sclerosis)(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- Medivir and Peptimmune jointly announced that an orally active, small molecule inhibitor of the protease enzyme Cathepsin S suppresses the development of chronic relapsing experimental autoimmune...

Mechanism that enables fetus to survive in mother under study.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- When the National Institutes of Health (NIH) requested proposals for innovative ideas in immune system suppression from scientists who aren't immunologists, Dr. Vadivel Ganapathy, biochemist, and his...

Lorus receives fast track designation from FDA for Virulizin.(Lorus Therapeutics Inc.)(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- Lorus Therapeutics, Inc., (Lorus) announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation for Virulizin in the treatment of pancreatic cancer. Virulizin is...

New research validates use of once-daily high dose 'good' bacteria in patients.(Questcor Pharmaceuticals Inc.)(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- Questcor Pharmaceuticals, Inc., (QSC) announced that new research presented here during the annual Digestive Disease Week (DDW) conference demonstrated that the company's therapeutic probiotic product,...

Proteome Systems launches ProteomIQ.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- Proteome Systems, Ltd., announced the release of ProteomIQ, an integrated comprehensive solution designed to accelerate proteomics research and the discovery of new drugs to treat diseases such as...

Versicor completes phase II study of once-weekly dalbavancin.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- Versicor, Inc., (VERS) announced the completion of enrollment of its phase II clinical trial with dalbavancin for the treatment of complicated skin and soft tissue infections. Dalbavancin is being...

Insulin sensitizer has anti-inflammatory effect in diabetics.(Brief Article)
July 10, 2002... 2002 JUL 10 - (NewsRx.com & NewsRx.net) -- A drug used widely as an insulin sensitizer appears also to have a significant anti-inflammatory effect in diabetics, a property that could make it useful in helping to prevent heart disease in these...

Researchers identify protein that regulates natural killer cells.(Brief Article)
July 17, 2002... 2002 JUL 17 - (NewsRx.com & NewsRx.net) -- Researchers at the University of Toronto and Mount Sinai Hospital have identified a protein that plays a critical role in the regulation of natural killer cells in the immune system's battle against...

Proinflammatory cytokine stimulates angiogenic factors in Lewis lung carcinoma.(Brief Article)
July 17, 2002... 2002 JUL 17 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - The inflammatory cytokine interleukin (IL)-1(beta) has been implicated in tumor angiogenesis by medical investigators in Japan. An examination of the role...

Not just a childhood disease.(asthma)(Brief Article)
July 17, 2002... 2002 JUL 17 - (NewsRx.com & NewsRx.net) -- While asthma is commonly thought of as a "childhood disease," it can also be diagnosed as a new condition in older people. According to the American Academy of Allergy, Asthma & Immunology (AAAAI),...

Probiotic bacteria at weaning may help alleviate allergy in infants.(Brief Article)
July 17, 2002... 2002 JUL 17 - (NewsRx.com & NewsRx.net) -- "Friendly" bacteria (probiotics) given to babies during weaning may help alleviate the symptoms of eczema, suggests research in Gut. The researchers studied 21 infants who already had evidence of...

Phase III data for D2E7 (adalimumab) support promise.(Statistical Data Included)
July 17, 2002... 2002 JUL 17 - (NewsRx.com & NewsRx.net) -- Results from phase III and ongoing clinical trials of Abbott Laboratories' investigational fully human monoclonal antibody, D2E7 (adalimumab), show a statistically significant reduction in the signs...

Conjugated CD20 vaccine elicits specific, polyclonal immune response in mice.(Brief Article)
July 17, 2002... 2002 JUL 17 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - The CD20 antigen, expressed only on B lineage cells before differentiation into plasma cells, produced a strong, specific, polyclonal immune response...

Ritonavir can reduce Kaposi sarcoma risk.(Brief Article)
July 17, 2002... 2002 JUL 17 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - The antiretroviral agent ritonavir may help prevent the development of Kaposi sarcoma (KS) in HIV patients, researchers in the United States report. ...

Antibody-resistant infection poorly controlled after DNA prime/boost regimens.(HIV viruses)(Brief Article)
July 17, 2002... 2002 JUL 17 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Potential HIV vaccines effective against some simian strains may not provide similar protection from the human version, researchers warn. "In the rhesus...

Thomas Stagnaro joins Protalex board of directors.(Brief Article)
July 17, 2002... 2002 JUL 17 - (NewsRx.com & NewsRx.net) -- Protalex, Inc., (PRTX) announced that Thomas Stagnaro has agreed to join its board of directors. Stagnaro is president and CEO of Agile Therapeutics. He formerly was president and CEO of...

Targeted Genetics presents preclinical data from arthritis program.(Brief Article)
July 17, 2002... 2002 JUL 17 - (NewsRx.com & NewsRx.net) -- Targeted Genetics Corporation (TGEN) presented additional data from the their arthritis program at the American Society of Gene Therapy Fifth Annual Meeting. An abstract entitled "Expression and...

Seattle biotech inks deal with BattellePharma.(Corus Pharma Inc.)(Brief Article)
July 17, 2002... 2002 JUL 17 - (NewsRx.com & NewsRx.net) -- Corus Pharma, a Seattle-based biotech and specialty pharmaceutical development company, announced a development and licensing agreement between BattellePharma and Corus's wholly owned subsidiary,...

Epimmune receives FDA clearance to initiate phase I/II therapeutic vaccine trial.(Brief Article)
July 17, 2002... 2002 JUL 17 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN), a biotechnology company focused on the development of pharmaceutical products using multiple, specific epitopes to activate the body's immune system, announced that it has...

Medarex and IDM announce partnership to develop cell drugs.(Immuno-Designed Molecules S.A.)(Brief Article)
July 17, 2002... 2002 JUL 17 - (NewsRx.com & NewsRx.net) -- Medarex, Inc., (MEDX) and Immuno-Designed Molecules S.A. (IDM), have entered into a joint development and supply agreement for the use of Medarex's MDX-010, an anti-CTLA-4 blocking antibody, in...

Clinical development begun of VX-702, p38 MAP kinase inhibitor.(Vertex Pharmaceuticals Inc.)(mitogen-activated protein)(Brief Article)
July 17, 2002... 2002 JUL 17 - (NewsRx.com & NewsRx.net) -- Vertex Pharmaceuticals Incorporated (VRTX) announced the initiation of a phase I clinical trial with VX-702, a novel, orally administered inhibitor of p38 mitogen-activated protein (MAP) kinase,...

State must pay for liver transplants, appeals court says.(Maryland Medicaid case)(Brief Article)
July 17, 2002... 2002 JUL 17 - (NewsRx.com & NewsRx.net) -- Maryland violated federal Medicaid guidelines when it refused to pay for liver transplants for two young patients, Maryland's highest court ruled June 21, 2002. The court said the state was...

Licofelone could rival COX-2 inhibitors.(Brief Article)
July 17, 2002... 2002 JUL 17 - (NewsRx.com & NewsRx.net) -- The results of the first of the phase III trials for licofelone have shown comparable efficacy to conventional NSAIDs but with excellent gastrointestinal (GI) and general tolerability. These...

Data shows Enbrel (etanercept) sustains efficacy and tolerability up to 5 years.(Brief Article)
July 17, 2002... 2002 JUL 17 - (NewsRx.com & NewsRx.net) -- Immunex Corporation (IMNX) announced data supporting the efficacy, tolerability and science of Enbrel (etanercept) at the 3rd annual European League Against Rheumatism Meeting. Data on Enbrel will...

HuMax-CD4 safe, well tolerated in clinical studies.(Brief Article)
July 17, 2002... 2002 JUL 17 - (NewsRx.com & NewsRx.net) -- Genmab A/S (GEN, GE9D) presented a summary of safety data to date from clinical studies with HuMax-CD4, its fully human antibody to treat rheumatoid arthritis (RA) and psoriasis, including blinded...

Enbrel treatment shows improvements in patient functionality.(Immunex Corp.)(Brief Article)
July 17, 2002... 2002 JUL 17 - (NewsRx.com & NewsRx.net) -- Immunex Corporation (IMNX) presented data on patients receiving Enbrel (etanercept) and experiencing improvement in physical functioning measurements as assessed by a validated health assessment...

Autoimmunity linked to childhood neurological disease.(Batten disease)
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- Basic studies with yeast, together with a new father's shock at the horrors wrought by a devastating childhood disease and a serendipitous guess by researchers, have led to important new findings about...

Loss of lean body mass in HIV-infected men linked to immunological processes.
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- AIDS and HIV infection have long been known to cause weight loss, a condition called AIDS wasting. With the advent of new medications, catastrophic wasting is no longer very common. However, what is...

Scientists watch individual T cells move in immune system.
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- For years, scientists studying the immune system have based their observations on snapshots of isolated cells and tissues. Now, thanks to emerging technologies, researchers can have front-row seats to...

White blood cells are much more active and dynamic than seen before.
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- White blood cells are much more active and dynamic than previously assumed and show complex behaviors for responding to foreign bodies, a University of California Irvine (UCI) study has shown for the...

COX-2 may play role in some brain tumors.
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- Oncologists at Jefferson Medical College have shown for the first time in two separate studies that the enzyme cyclooxygenase-2 (COX-2), which is the target for the popular antiarthritis drugs - and...

Blood stem cell transplantation holds hope for autoimmune diseases.
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- For patients with severe autoimmune diseases, blood stem cell transplantation may be promising therapy option. This process involves an infusion of healthy blood cells to replace the body's own...

Noncytotoxic antiviral mechanisms contribute to persistent infection resistance.
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Italy have elucidated factors contributing to the strong resistance to HIV infection seen in some repeatedly exposed individuals. "In...

Avanir subsidiary awarded funding to develop monoclonal antibody treatment.(Xenerex Biosciences)
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- Xenerex Biosciences, a subsidiary of Avanir Pharmaceuticals (AVN), announced that it has been notified it will receive $75,000 from the Center for Commercialization of Advanced Technology (CCAT). The...

Successful antiretroviral treatment has little effect on overall immune function.(in HIV)
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Successful antiretroviral therapy has surprisingly meager effects on overall immune function in HIV patients, researchers say. Dr. Christopher G. Lange...

Staph-link protein may prove helpful for therapy.(Staphylococcus aureus may be used to treat arthritis)
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- A protein that makes staph infections more dangerous by blocking the body's immune defenses may help point the way to better treatments for arthritis and other diseases. The bacteria...

PDL begins phase II trial of SMART anti-(gamma) interferon antibody.(Protein Design Labs Inc.)
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- Protein Design Labs, Inc., (PDLI) has initiated a phase II clinical trial to evaluate its humanized SMART antigamma interferon antibody in Crohn disease. The phase II clinical trial is a...

Sheffield presents positive data on pulmonary drug delivery technologies.(Sheffield Pharmaceuticals Inc.)
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- Sheffield Pharmaceuticals, Inc., (SHM) reported results of clinical trials for its Unit Dose Budesonide drug product and the Tempo Inhaler at the Respiratory Drug Delivery VIII Conference in Tucson,...

Immunomedics announces additional interim results of epratuzumab combination in treating non-Hodgkin lymphoma.(epratuzumab, rituximab combination)(Brief Article)
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- Immunomedics, Inc., (IMMU) announced at the 38th annual meeting of the American Society of Clinical Oncology in Orlando, Florida, that interim results of the phase II clinical trial testing the cancer...

Chemical produced by bug may be useful medicine.(Staphylococcus aureus for the treatment of rheumatoid arthritis, atherosclerosis, and tumor metastasis)(Brief Article)
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- When the human body is threatened with infection, it mounts a defense that includes a rush of cells of the immune system to the site of infection. To achieve locomotion through the body, these cells...

Patent issued for culture and encapsulation of pancreatic islet cells for transplantation.(Brief Article)
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- MicroIslet, Inc., (MIIS) announced that the United States Patent Office has granted patent number 6,365,385, which is licensed exclusively to the company under its license agreement with Duke...

Survey: Few are aware of prevalence of IBS.(irritable bowel syndrome)(Brief Article)
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- A new survey of 1000 adults released during the 33rd annual Digestive Disease Week shows that Americans are not aware of the widespread presence of irritable bowel syndrome (IBS). IBS affects up...

Worldwide hepatitis C market expected to reach $3.97 billion by 2007.
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- The worldwide market for hepatitis C therapeutics is expected to reach nearly $4 billion by 2007, driven both by a growing patient population and the emergence of promising new drugs. For example...

Pneumococcal surveillance emphasizes need for protective strategies.
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- by Roxanne Nelson, staff medical writer - The overall incidence in pneumococcal disease in Denmark has gone down, report researchers, but there is an increase in antibiotic-resistant strains. In...

Researchers question claims for embattled egg powder.(OvImmune Inc.)
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- Marilyn Coleman moved from the suburbs of Ohio nearly 2 years ago so she'd have room for 10,000 chickens laying "magic bullets" she said can boost the human immune system. That was before a U.S....

Airflow limitation in infants persists into childhood.
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- A group of 23 Australian infants who demonstrated flow limitation in expiratory breathing at 4 weeks of age continued to have reduced lung function ability and increased airway resistance through age...

Potential of regenerative medicine explored.(Brief Article)
July 24, 2002... 2002 JUL 24 - (NewsRx.com & NewsRx.net) -- Clinical and basic science research findings of more than a dozen studies were presented by researchers from the University of Pittsburgh's McGowan Institute for Regenerative Medicine at the 48th...